NCT03851471View on ClinicalTrials.gov

Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 7, 2019

Primary Completion Date

July 24, 2020

Study Completion Date

March 30, 2021

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Jiu-wei-zhen-xiao Granule

Patients will be treated for 12 weeks, with oral administration of 5g once of Jiu-wei-zhen-xiao Granule,three times a day, based on the conventional treatment for HCC, such as antiviral treatment, supportive treatment or symptomatic treatment.

Trial Locations (1)

430061

Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan

All Listed Sponsors
lead

Zhong Wang

OTHER

NCT03851471 - Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter